186 related articles for article (PubMed ID: 30409422)
1. Mesenchymal stem cells induced CD4+ T cell apoptosis in treatment of lupus mice.
Huang S; Wu S; Zhang Z; Deng W; Fan J; Feng R; Kong W; Qi J; Chen W; Tang X; Yao G; Feng X; Wang D; Chen H; Sun L
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):30-35. PubMed ID: 30409422
[TBL] [Abstract][Full Text] [Related]
2. Human umbilical cord-derived mesenchymal stem cell therapy ameliorates lupus through increasing CD4+ T cell senescence via MiR-199a-5p/Sirt1/p53 axis.
Cheng T; Ding S; Liu S; Li Y; Sun L
Theranostics; 2021; 11(2):893-905. PubMed ID: 33391511
[No Abstract] [Full Text] [Related]
3. No significant effects of Poly(I:C) on human umbilical cord-derived mesenchymal stem cells in the treatment of B6.MRL-Fas(lpr) mice.
Huang S; Wang D; Gu F; Zhang Z; Deng W; Chen W; Tang X; Yao G; Feng X; Sun L
Curr Res Transl Med; 2016; 64(2):55-60. PubMed ID: 27316386
[TBL] [Abstract][Full Text] [Related]
4. Human Umbilical Cord Mesenchymal Stem Cells Inhibit T Follicular Helper Cell Expansion Through the Activation of iNOS in Lupus-Prone B6.MRL-
Zhang Z; Feng R; Niu L; Huang S; Deng W; Shi B; Yao G; Chen W; Tang X; Gao X; Feng X; Sun L
Cell Transplant; 2017 Jun; 26(6):1031-1042. PubMed ID: 28105982
[TBL] [Abstract][Full Text] [Related]
5. Double-Edged Effect of Hydroxychloroquine on Human Umbilical Cord-Derived Mesenchymal Stem Cells Treating Lupus Nephritis in MRL/lpr Mice.
Mai S; Zou L; Tian X; Liao X; Luan Y; Han X; Wei Y; Wu Y; Kuang S; Yang Y; Ma J; Chen Q; Yang J
Mol Pharm; 2018 May; 15(5):1800-1813. PubMed ID: 29668284
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cells upregulate Treg cells via sHLA-G in SLE patients.
Chen C; Liang J; Yao G; Chen H; Shi B; Zhang Z; Zhao C; Zhang H; Sun L
Int Immunopharmacol; 2017 Mar; 44():234-241. PubMed ID: 28129605
[TBL] [Abstract][Full Text] [Related]
7. EGR2 is elevated and positively regulates inflammatory IFNγ production in lupus CD4
Dai R; Heid B; Xu X; Xie H; Reilly CM; Ahmed SA
BMC Immunol; 2020 Jul; 21(1):41. PubMed ID: 32646370
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cells prevent podocyte injury in lupus-prone B6.MRL-Faslpr mice via polarizing macrophage into an anti-inflammatory phenotype.
Zhang Z; Niu L; Tang X; Feng R; Yao G; Chen W; Li W; Feng X; Chen H; Sun L
Nephrol Dial Transplant; 2019 Apr; 34(4):597-605. PubMed ID: 29982691
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal Stem Cells-derived Exosomes Ameliorate Lupus by Inducing M2 Macrophage Polarization and Regulatory T Cell Expansion in MRL/lpr Mice.
Sun W; Yan S; Yang C; Yang J; Wang H; Li C; Zhang L; Zhao L; Zhang J; Cheng M; Li X; Xu D
Immunol Invest; 2022 Aug; 51(6):1785-1803. PubMed ID: 35332841
[TBL] [Abstract][Full Text] [Related]
10. Characterization of reciprocal Lmb1-4 interval MRL-Faslpr and C57BL/6-Faslpr congenic mice reveals significant effects from Lmb3.
Santiago-Raber ML; Haraldsson MK; Theofilopoulos AN; Kono DH
J Immunol; 2007 Jun; 178(12):8195-202. PubMed ID: 17548658
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow-derived mesenchymal stem cells inhibit T follicular helper cell in lupus-prone mice.
Yang X; Yang J; Li X; Ma W; Zou H
Lupus; 2018 Jan; 27(1):49-59. PubMed ID: 28537524
[TBL] [Abstract][Full Text] [Related]
12. Human embryonic mesenchymal stem cells alleviate pathologic changes of MRL/Lpr mice by regulating Th7 cell differentiation.
Yuan L; Xiao ZT; Huang XZ; Wu MJ; Shi H; Liu AF
Ren Fail; 2016 Oct; 38(9):1432-1440. PubMed ID: 27416851
[TBL] [Abstract][Full Text] [Related]
13. MiR-153-3p induces immune dysregulation by inhibiting PELI1 expression in umbilical cord-derived mesenchymal stem cells in patients with systemic lupus erythematosus.
Li D; Li X; Duan M; Dou Y; Feng Y; Nan N; Zhang W
Autoimmunity; 2020 Jun; 53(4):201-209. PubMed ID: 32321315
[TBL] [Abstract][Full Text] [Related]
14. Differential effect of allogeneic versus syngeneic mesenchymal stem cell transplantation in MRL/lpr and (NZB/NZW)F1 mice.
Gu F; Molano I; Ruiz P; Sun L; Gilkeson GS
Clin Immunol; 2012 Nov; 145(2):142-52. PubMed ID: 23041504
[TBL] [Abstract][Full Text] [Related]
15.
Nagasu A; Mukai T; Iseki M; Kawahara K; Tsuji S; Nagasu H; Ueki Y; Ishihara K; Kashihara N; Morita Y
Cells; 2019 Apr; 8(5):. PubMed ID: 31052273
[TBL] [Abstract][Full Text] [Related]
16. Effect of nonmyeloablative unrelated fetal and neonatal murine peripheral blood mononuclear cell infusion on MRL/lpr mice.
Chuan W; Wu-qing W; Zhu-wen Y; Zuo L
Lupus; 2014 Sep; 23(10):994-1005. PubMed ID: 24756437
[TBL] [Abstract][Full Text] [Related]
17. Transplantation of mesenchymal stem cells ameliorates systemic lupus erythematosus and upregulates B10 cells through TGF-β1.
Chun W; Tian J; Zhang Y
Stem Cell Res Ther; 2021 Sep; 12(1):512. PubMed ID: 34563233
[TBL] [Abstract][Full Text] [Related]
18. Regulation of T cell-dependent autoantibody production by a gammadelta T cell line derived from lupus-prone mice.
Fujii T; Okada M; Craft J
Cell Immunol; 2002; 217(1-2):23-35. PubMed ID: 12425998
[TBL] [Abstract][Full Text] [Related]
19. Deletion of receptor for advanced glycation end products exacerbates lymphoproliferative syndrome and lupus nephritis in B6-MRL Fas lpr/j mice.
Goury A; Meghraoui-Kheddar A; Belmokhtar K; Vuiblet V; Ortillon J; Jaisson S; Devy J; Le Naour R; Tabary T; Cohen JH; Schmidt AM; Rieu P; Touré F
J Immunol; 2015 Apr; 194(8):3612-22. PubMed ID: 25762779
[TBL] [Abstract][Full Text] [Related]
20. Transplantation of mesenchymal stem cells ameliorates secondary osteoporosis through interleukin-17-impaired functions of recipient bone marrow mesenchymal stem cells in MRL/lpr mice.
Ma L; Aijima R; Hoshino Y; Yamaza H; Tomoda E; Tanaka Y; Sonoda S; Song G; Zhao W; Nonaka K; Shi S; Yamaza T
Stem Cell Res Ther; 2015 May; 6(1):104. PubMed ID: 26012584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
